Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00232388 · ClinicalTrials.gov registry record
Association of PICP Serum Marker in Patients With LVSD
A clinical trial, sponsored by Texas Tech University Health Sciences Center.
- Terminated
- Registry status
- 45
- Enrollment target
NCT00232388 is a clinical trial that was terminated before completion, run by Texas Tech University Health Sciences Center. The registered enrollment target is 45 participants.
The verdict
NCT00232388 was terminated before completion, sponsored by Texas Tech University Health Sciences Center.
- TERMINATED
- Registry status
- 45 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if the carboxy-terminal of procollagen type I (PICP) can be a useful marker of different degrees of myocardial fibrosis.
Interventions
- PROCEDURE Blood draw
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2005-09 |
| Est. Completion | 2007-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00232388
The ClinicalTrials.gov registry entry for NCT00232388 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Texas Tech University Health Sciences Center, which has 76 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Blood draw is the first listed.
NCT00232388 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00232388 about?
NCT00232388 is a clinical study titled "Association of PICP Serum Marker in Patients With LVSD". The purpose of this study is to determine if the carboxy-terminal of procollagen type I (PICP) can be a useful marker of different degrees of myocardial fibrosis.
What is the current status of trial NCT00232388?
This trial is currently terminated. The enrollment target is 45 participants. The study started on 2005-09. Estimated completion is 2007-09.
What interventions are being tested in trial NCT00232388?
The interventions under investigation include: Blood draw (PROCEDURE).
Who is sponsoring clinical trial NCT00232388?
This trial is sponsored by Texas Tech University Health Sciences Center, which has 76 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.